trans-1,4-Dibromo-2-butene CAS 821-06-7 Pite ≥99.0% (GC) Faktori Segondè Kalite
Manifakti ak kalite siperyè ak pri konpetitif
Pwovizyon komèsyal Aliskiren ki gen rapò ak entèmedyè:
Aliskiren CAS: 173334-57-1
Aliskiren Hemifumarate CAS: 173334-58-2
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R)-4-Benzyl-2-Oxazolidinone CAS: 102029-44-7
trans-1,4-Dibromo-2-Butene CAS: 821-06-7
Isovaleryl klori CAS: 108-12-3
D-Phenylalanine CAS: 673-06-3
D-Phenylalaninol CAS: 5267-64-1
Non Chimik | trans-1,4-Dibromo-2-Butene |
Sinonim | (E) -1,4-Dibromobut-2-ene;(2E) -1,4-Dibromo-2-butèn |
Nimewo CAS | 821-06-7 |
Nimewo CAT | RF-PI149 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C4H6Br2 |
Pwa molekilè | 213.9 |
Solibilite nan metanol | Prèske transparans |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Blan a mawon solid |
Pite / Metòd analiz | ≥99.0% (GC) |
Cis-Contenu | ≤0.20% |
Pwen k ap fonn | 50.0 ℃ ~ 54.0 ℃ |
Tetrabromobutan (TBB) | ≤0.50% |
Imidite (KF) | ≤0.20% |
Tès Creole | Enterprise Standard |
Itilizasyon | Aliskiren (CAS 173334-57-1), Aliskiren Hemifumarate (CAS 173334-58-2) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![2](https://www.ruifuchemical.com/uploads/23.jpg)
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) ak kalite siperyè, lajman ki itilize nan sentèz òganik, sentèz entèmedyè pharmaceutique ak sentèz engredyan aktif pharmaceutique (API).
trans-1,4-Dibromo-2-Butene (CAS: 821-06-7) se yon entèmedyè kle nan sentèz Aliskiren (CAS: 173334-57-1), API.Aliskiren se yon premye nan klas dwòg antihypertensive ki aji pa anpèchman dirèk nan renin.Li endike pou administrasyon oral swa kòm monoterapi oswa nan konbinezon ak lòt ajan antiipèrtansif.Anpèchman renin pa aliskiren rezilta nan nivo redwi nan anjyotansin I, anjyotansin II, ak aldosteron, tout nan yo ki kontribye nan efè a antihypertensive.